Cargando…

CD8(+) T Cell Responses during HCV Infection and HCC

Chronic hepatitis C virus (cHCV) infection is a major global health burden and the leading cause of hepatocellular carcinoma (HCC) in the Western world. The course and outcome of HCV infection is centrally influenced by CD8(+) T cell responses. Indeed, strong virus-specific CD8(+) T cell responses a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hofmann, Maike, Tauber, Catrin, Hensel, Nina, Thimme, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957882/ https://www.ncbi.nlm.nih.gov/pubmed/33801203 http://dx.doi.org/10.3390/jcm10050991

Ejemplares similares

HCV-Specific T Cell Responses During and After Chronic HCV Infection
por: Luxenburger, Hendrik, et al.
Publicado: (2018)

Priming persistence of HCV
por: Schuch, Anita, et al.
Publicado: (2015)

Inefficient induction of circulating TAA-specific CD8+ T-cell responses in hepatocellular carcinoma
por: Tauber, Catrin, et al.
Publicado: (2019)

Heterogeneity of HBV-Specific CD8(+) T-Cell Failure: Implications for Immunotherapy
por: Heim, Kathrin, et al.
Publicado: (2019)

Adaptive Immune Responses, Immune Escape and Immune-Mediated Pathogenesis during HDV Infection
por: Oberhardt, Valerie, et al.
Publicado: (2022)

TOX defines the degree of CD8+ T cell dysfunction in distinct phases of chronic HBV infection
por: Heim, Kathrin, et al.
Publicado: (2021)

Methodologies for the Analysis of HCV-Specific CD4(+) T Cells
por: Lokhande, Megha U., et al.
Publicado: (2015)

Transcriptional insights into the CD8(+) T cell response in mono-HIV and HCV infection
por: Li, Si-Yao, et al.
Publicado: (2020)

Interleukin-6 polymorphisms in HCC patients chronically infected with HCV
por: Adnan, Faisal, et al.
Publicado: (2020)

CD8 Epitope Escape and Reversion in Acute HCV Infection
por: Timm, Joerg, et al.
Publicado: (2004)

Bystander hyperactivation of preimmune CD8(+) T cells in chronic HCV patients
por: Alanio, Cécile, et al.
Publicado: (2015)

ERAP1 allotypes shape the epitope repertoire of virus-specific CD8(+) T cell responses in acute hepatitis C virus infection
por: Kemming, Janine, et al.
Publicado: (2019)

HCV and HCC Tango—Deciphering the Intricate Dance of Disease: A Review Article
por: Milosevic, Ivana, et al.
Publicado: (2023)

Coexpression of PD-1, 2B4, CD160 and KLRG1 on Exhausted HCV-Specific CD8+ T Cells Is Linked to Antigen Recognition and T Cell Differentiation
por: Bengsch, Bertram, et al.
Publicado: (2010)

SARS-CoV-2-Specific T Cell Responses in Immunocompromised Individuals with Cancer, HIV or Solid Organ Transplants
por: Reeg, David B., et al.
Publicado: (2023)

Transcriptomic Assay of CD8(+) T Cells in Treatment-Naïve HIV, HCV-Mono-Infected and HIV/HCV-Co-Infected Chinese
por: Zhao, Jin, et al.
Publicado: (2012)

The Role of Natural Killer Cells and CD8(+) T Cells in Hepatitis B Virus Infection
por: Schuch, Anita, et al.
Publicado: (2014)

The Role of Stem Cell Factor, Epidermal Growth Factor and Angiopoietin-2 in HBV, HCV, HCC and NAFLD
por: Radmanić, Leona, et al.
Publicado: (2022)

Hepatitis B vaccine and NK cells: a new player in memory
por: Hofmann, Maike, et al.
Publicado: (2021)

Molecular Signature and Immune Landscape of HCV-Associated Hepatocellular Carcinoma (HCC): Differences and Similarities with HBV-HCC
por: De Battista, Davide, et al.
Publicado: (2021)

TCF1(+) hepatitis C virus-specific CD8(+) T cells are maintained after cessation of chronic antigen stimulation
por: Wieland, Dominik, et al.
Publicado: (2017)

Gamma-Chain Receptor Cytokines & PD-1 Manipulation to Restore HCV-Specific CD8(+) T Cell Response during Chronic Hepatitis C
por: Peña-Asensio, Julia, et al.
Publicado: (2021)

Epigenetic Mechanisms Involved in HCV-Induced Hepatocellular Carcinoma (HCC)
por: Zhao, Pin, et al.
Publicado: (2021)

Immunomodulation of the Natural Killer Cell Phenotype and Response during HCV Infection
por: Njiomegnie, Gaitan Fabrice, et al.
Publicado: (2020)

Timing of DAA Initiation After Curative Treatment and Its Relationship with the Recurrence of HCV-Related HCC
por: Gao, Xiuzhu, et al.
Publicado: (2020)

CD81 and Hepatitis C Virus (HCV) Infection
por: Fénéant, Lucie, et al.
Publicado: (2014)

Strong Vaccine-Induced CD8 T-Cell Responses Have Cytolytic Function in a Chimpanzee Clearing HCV Infection
por: Verstrepen, Babs E., et al.
Publicado: (2014)

Plasma lipids, tumor parameters and survival in HCC patients with HBV and HCV
por: Akkiz, H, et al.
Publicado: (2020)

Sorafenib in the Treatment of Virus-Related HCC: Differences Between HCV and HBV
por: De Matteis, Serena, et al.
Publicado: (2021)

The Natural Killer Cell Response to HCV Infection
por: Ahlenstiel, Golo
Publicado: (2013)

Problems of Long Survival Following Surgery in Patients with NonBNonC-HCC: Comparison with HBV and HCV Related-HCC
por: Hiwatashi, Kiyokazu, et al.
Publicado: (2015)

Targeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infection
por: Barili, Valeria, et al.
Publicado: (2020)

Interferon Response in Hepatitis C Virus (HCV) Infection: Lessons from Cell Culture Systems of HCV Infection
por: Sung, Pil Soo, et al.
Publicado: (2015)

Establishment and validation of exhausted CD8+ T cell feature as a prognostic model of HCC
por: Shi, Jihang, et al.
Publicado: (2023)

HCV Eradication with Direct-Acting Antivirals Does Not Impact HCC Progression on the Waiting List or HCC Recurrence after Liver Transplantation
por: Emamaullee, Juliet A., et al.
Publicado: (2019)

Pre-existing immunity and vaccine history determine hemagglutinin-specific CD4 T cell and IgG response following seasonal influenza vaccination
por: Wild, Katharina, et al.
Publicado: (2021)

Chronic HCV infection promotes cytotoxicity in antigen-specific CD8(+) T cells regardless of virus specificity
por: Maretti-Mira, Ana C., et al.
Publicado: (2023)

HCV-specific CD4+ T cells of patients with acute and chronic HCV infection display high expression of TIGIT and other co-inhibitory molecules
por: Ackermann, Christin, et al.
Publicado: (2019)

SARS-CoV-2 vaccination can elicit a CD8 T-cell dominant hepatitis
por: Boettler, Tobias, et al.
Publicado: (2022)

Oral Zinc Supplementation Decreases the Risk of HCC Development in Patients With HCV Eradicated by DAA
por: Hosui, Atsushi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6m3sn0eke7ofvvg6gobhnecj1g